Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Amalia Rodriguez French"'
Autor:
German Henostroza, Yarineth Quintero, Amalia Rodriguez-French, Katiana Castillo, Erika Santiago, Enrique Adames, Ana Belén Araúz, Boris Castillo
Publikováno v:
Emerging Infectious Diseases. 26:118-121
Melioidosis is an infection caused by Burkholderia pseudomallei. Most cases occur in Southeast Asia and northern Australia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26ce71be306079e9f448f88359344900
https://doi.org/10.3201/eid2601.180870
https://doi.org/10.3201/eid2601.180870
Autor:
Amalia Rodriguez-French, Ana Belén Araúz, Israel Cedeño, Paige A. Armstrong, Shawn R. Lockhart, Brendan R Jackson, Elizabeth L. Berkow, Andres Espinosa-Bode, Tom Chiller, Erika Santiago, Lizbeth Hayer, Carolina Ramos, Susan Arosemena, Nestor Sosa, Jovanna Borace, Diego H. Cáceres
Publikováno v:
Mycoses. 61(1)
Candida auris is an emerging multidrug-resistant (MDR) fungus associated with invasive infections and high mortality. This report describes 9 patients from whom C. auris was isolated at a hospital in Panama City, Panama, the first such cases in Centr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::640c6f2523e34f11785bcc69ac892f74
https://pubmed.ncbi.nlm.nih.gov/28945325
https://pubmed.ncbi.nlm.nih.gov/28945325
Autor:
Elizabeth L. Berkow, Nestor Sosa, Lizbeth Hayer, Israel Cedeño, Carolina Ramos, Ana Belen Arauz Rodriguez, Susan Arosemena, Shawn R. Lockhart, Diego H Caceres, Andres Espinosa-Bode, Paige A. Armstrong, Erika Santiago, Amalia Rodriguez French, Tom Chiller, Brendan R Jackson, Jovanna Borace
Publikováno v:
Open Forum Infectious Diseases
Background Candida auris is an emerging multidrug-resistant pathogen associated with invasive infections and high mortality. This report describes the first 9 cases of C. auris in Central America in a hospital in Panama City, Panama, and highlights t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49727d8768ebd78b3054c5c0bb6564f7
http://europepmc.org/articles/PMC5630720
http://europepmc.org/articles/PMC5630720
Autor:
Tom Van De Casteele, Don Kilby, Adriano Lazzarin, Ralph DeMasi, Pere Domingo, Jan Fourie, Sabrina Spinosa-Guzman, Ludo Lavreys, Juan Ballesteros, Amalia Rodriguez-French, Jason Flamm, Nestor Sosa
Publikováno v:
HIV clinical trials. 12(6)
ARTEMIS demonstrated significantly greater efficacy of once-daily darunavir/ritonavir (DRV/r) 800/100 mg versus lopinavir/ritonavir 800/200 mg (total daily dose) in treatment-naïve, HIV-1-infected patients at week 96. The influence of baseline chara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7e2b3d35572cbddb26f6cf7dc83d9cf
https://pubmed.ncbi.nlm.nih.gov/22189150
https://pubmed.ncbi.nlm.nih.gov/22189150
Autor:
Gladys E Sepulveda, Jeffrey P. Nadler, Amalia Rodriguez-French, Judith Millard, Paul G Wannamaker, Arnaldo R Quinones, Glenda Gray, Jack Boghossian
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 35(1)
Poor tolerability is a major cause of nonadherence and treatment discontinuation with protease inhibitors (PIs). Gastrointestinal (GI) disturbances are often cited as affecting PI tolerability, but other adverse effects, such as those that affect pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0ad4e9aba69467eccd31818258bdd82
https://pubmed.ncbi.nlm.nih.gov/14707788
https://pubmed.ncbi.nlm.nih.gov/14707788